(Q45875190)

17 December 2017

title

Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines (English)

1 reference

17 December 2017

author name string

Burger JA

series ordinal

1

1 reference

17 December 2017

Mendoza RB

series ordinal

2

1 reference

17 December 2017

Kipps TJ

series ordinal

3

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

17 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

15-16

1 reference

17 December 2017

page(s)

2181-2189

1 reference

17 December 2017

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Activation of human dendritic cells through CD40 cross-linking.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Reduction in mitochondrial membrane potential is an early event in Fas-independent CTL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900382-0

7 January 2021

10.1016/S0264-410X(00)00382-0

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017